Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Med Chem. 2010 Dec;45(12):5662-70. doi: 10.1016/j.ejmech.2010.09.020. Epub 2010 Sep 17.

Mitogen-activated protein kinase 4 of Leishmania parasite as a therapeutic target.

Author information

1
Department of Biotechnology, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.

Abstract

Protein kinases are important regulators of many different cellular processes such as transcriptional control, cell cycle progression and differentiation, and have drawn much attention as potential drug targets. Leishmania mexicana mitogen-activated protein kinase 4 (LmxMPK4) is crucial for the survival of the parasite. As the crystal structure of the enzyme is not known, we have used bioinformatics techniques to model LmxMPK4 structure. The current study reveals conservation of all sequence and structural motifs of LmxMPK4. Study shows mitogen-activated protein kinases are highly conserved throughout different Leishmania species and significant divergence is observed towards mammalian mitogen-activated protein kinases. Additionally, using virtual docking methods, we have identified inhibitors for LmxMPK4. The sequence and structure analysis results were helpful in identifying the ligand binding sites and molecular function of the Leishmania specific mitogen-activated protein kinase.

PMID:
20884088
DOI:
10.1016/j.ejmech.2010.09.020
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center